Supernus Pharmaceuticals (SUPN) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Supernus Pharmaceuticals (SUPN) Company Statistics | The Fly

Supernus Pharmaceuticals

· SUPN

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

2.56 B

-2.12%

General

Market Cap: $2.56B
Enterprise Value: $2.36B
Shares Outstanding: 58,040,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 88.07%
Operating Margin: -13.46%
Net Profit Margin: -13.23%
FCF Margin: 2.26%
ROA: -7.69%
ROE: -10.42%
ROIC: -9.12%
Current Ratio: 2.08
Debt-to-Equity: 0.04
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 3.01
P/FCF: 132.97
P/B: 2.42
EV/EBITDA: -148.62

Growth

Rev 1Y: 8.63%
Rev 1Y Fwd Est: 22.27%
Rev 3Y (CAGR): 2.52%
Rev 5Y (CAGR): 6.68%

Income Statement (TTM)

Revenue: $830.44M
Gross Margin: 88.07%
Operating Expenses: $844.11M
Operating Income: -$111.81M
Net Profit: -$109.89M

Balance Sheet

Rev 10Y (CAGR)

17.41%

EPS 1Y

-151.52%

EPS 1Y Fwd Est

—

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $179.95M
Working Capital: $376.12M
Total Assets: $1.43B
Net Debt: -$139.78M
Total Liabilities: $396.88M
Total Equity: $1.03B

Cash Flow Statement (TTM)

Cash Flow from Operations: $19.91M
Cash Flow from Investing: -$14.73M
Cash Flow from Financing: $31.51M
Free Cash Flow: $18.79M
Capital Expenditures: $1.12M